Tradestie Institutional Equity Comparison Engine

IVF vs ILLR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IVF Overall Edge

IVF Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to INVO Fertility, Inc. Common Stock (IVF) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, IVF trades at N/M Forward P/E with -78.7% operating margin (+16.7% YoY revenue) versus ILLR at N/M Forward P/E and -432.7% operating margin (-5.2% YoY). In options structure, IVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ILLR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IVF
IVF N/M vs ILLR N/M Fwd P/E
Growth & Margin Winner IVF
Op Margin -78.7% vs -432.7% ยท YoY +16.7% vs -5.2%
Momentum & Technical Winner IVF
1Y +376.9% vs -76.1% ยท 52W Pos 49% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IVF NASDAQ
INVO Fertility, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$2.38
-8.46% 1D
Market Cap $3.2M
1M Return +326.83%
1Y Return +376.95%
Forward P/E N/M
Unified AI Score
29.8 / 100 SELL
Tech 50.0 Fund 26.0 Flow 50.0 Mom 34.0
ILLR NASDAQ
Triller Group Inc. Common Stock
Investment Advice
$0.18
-23.04% 1D
Market Cap $4.7M
1M Return -80.49%
1Y Return -76.08%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 45.0 Fund 49.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IVF +376.95% ILLR -76.08% Spread: +125.04 pp (IVF Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IVF Revenue ILLR Revenue IVF Op. Margin ILLR Op. Margin Margin Edge
FY2018 $0M N/A -532.8% N/A IVF
FY2019 $0M N/A -120.8% N/A IVF
FY2020 $0M N/A -531.7% N/A IVF
FY2021 $0M $10M -125.4% -73.7% ILLR
FY2022 $0M $30M -1292.5% -91.2% ILLR
FY2023 $0M $50M -224.0% -79.5% ILLR
FY2024 $10M $30M -101.0% -411.9% IVF
FY2025 $10M $20M -105.8% -640.1% IVF

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IVF (4) vs ILLR (4)
Institutional Metric IVF ILLR Criterion Row Winner
Market Capitalization Scale $3.2M $4.7M Larger Scale Tie
Trailing P/E Ratio Valuation 0.0x N/M Lower Multiple IVF
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +16.7% -5.2% Higher Growth IVF
Operating Margin (TTM) Profitability -78.7% -432.7% Higher Margin IVF
Net Profit Margin Profitability -92.3% 0.0% Higher Margin ILLR
Return on Equity (ROE) Capital Efficiency -72.7% 0.0% Higher ROE ILLR
52-Week Range Position Momentum 49% ($0โ€“$5) 1% ($0โ€“$5) Stronger Trend IVF
Beta / 30D Volatility Risk Regime -7.15ฮฒ ยท 888% Vol -10.16ฮฒ ยท 177% Vol Lower Realized Risk ILLR
Unified Institutional Score Composite Signal 29.8 / 100 (SELL) 48.6 / 100 (HOLD) Higher Composite ILLR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IVF vs ILLR Buy Guide
IVF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IVF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ILLR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ILLR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IVF nor ILLR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.